Niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD): Correlative measures of tumor response in phase II GALAHAD study Meeting Abstract
| Authors: | Smith, M. R.; Fizazi, K.; Sandhu, S. K.; Kelly, W. K.; Efstathiou, E.; Lara, P.; Yu, E. Y.; George, D. J.; Chi, K. N.; Saad, F.; Summa, J.; Freedman, J. M.; Mason, G.; Espina, B. M.; Zhu, E.; Ricci, D. S.; Snyder, L. A.; Simon, J. S.; Cheng, S.; Scher, H. I. |
| Abstract Title: | Niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD): Correlative measures of tumor response in phase II GALAHAD study |
| Meeting Title: | 2020 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2020 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-20 |
| Language: | English |
| ACCESSION: | WOS:000529525900187 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.6_suppl.118 |
| Notes: | Meeting Abstract: 118 -- Source: Wos |
